AIG
MLYS icon

American International Group’s Mineralys Therapeutics MLYS Stock Holding History

American International Group’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,573
Closed -$124K – 1638
2024
Q1 		$124K Sell
9,573
-83
-0.9% -$1.02K ﹤0.01% 2402
2023
Q4 		$83K Buy
9,656
+2,692
+39% +$21.1K ﹤0.01% 2655
2023
Q3 		$66.2K Buy
6,964
+247
+4% +$3.22K ﹤0.01% 2734
2023
Q2 		$115K Buy
6,717
+878
+15% +$13.1K ﹤0.01% 2492
2023
Q1 		$91.4K Buy
+5,839
New +$98.3K ﹤0.01% 2499

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

American International Group's MLYS Position: Q2 2024 in Review

American International Group sold out of Mineralys Therapeutics (MLYS) in Q2 2024, closing a stake of 9,573 shares — an estimated $124K sold.

American International Group first reported a position in MLYS in Q1 2023 and held it in 5 quarters. The position peaked at $124K in Q1 2024. 94 funds tracked by Wall St. Rank hold MLYS as of Q2 2024.

  • American International Group reported no remaining Mineralys Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 9,573 Mineralys Therapeutics shares in Q2 2024, an estimated $124K.
  • American International Group first reported a position in Mineralys Therapeutics in Q1 2023 and held it in 5 quarters.
  • American International Group's Mineralys Therapeutics position peaked at $124K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.